gabapentin has been researched along with Chronic Inflammatory Demyelinating Polyradiculoneuropathy in 1 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Excerpt | Relevance | Reference |
---|---|---|
"Healthcare costs for CIDP patients are substantial, with a large burden in pharmacy usage." | 1.40 | Patient demographics and health plan paid costs in chronic inflammatory demyelinating polyneuropathy. ( Bromberg, MB; Guptill, JT; Krueger, A; Sanders, DB; Sharma, BK; Thompson, AR; Zhu, L, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guptill, JT | 1 |
Bromberg, MB | 1 |
Zhu, L | 1 |
Sharma, BK | 1 |
Thompson, AR | 1 |
Krueger, A | 1 |
Sanders, DB | 1 |
1 other study available for gabapentin and Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Article | Year |
---|---|
Patient demographics and health plan paid costs in chronic inflammatory demyelinating polyneuropathy.
Topics: Adolescent; Adult; Aged; Algorithms; Amines; Analgesics; Anti-Inflammatory Agents; Comorbidity; Cost | 2014 |